Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The REVeAL-HF Trial: Risk EValuation And Its Impact on ClinicAL Decision Making and Outcomes in Heart Failure

NCT03845660 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT03845660
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03845660 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The REVeAL-HF Trial: Risk EValuation And Its Impact on ClinicAL Decision Making and Outcomes in Heart Failure
Lead sponsor
Yale University
Phase
Not applicable
Overall status
Completed
Start date
January 1, 2020
Completion date
December 30, 2021
Enrollment
3,124 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure